Examkin

Question

Difficulty: MediumNeoplastic Processes

An emergency department physician evaluates a 34-year-old woman presenting with a 3-day history of continuous epistaxis, heavy menstrual bleeding, and diffuse ecchymoses. She reports profound fatigue over the past week but denies fever or weight loss. Her temperature is 37.1°C (98.8°F), blood pressure is 110/70 mmHg, and pulse is 105/min. Physical examination reveals widespread petechiae over her lower extremities.

Laboratory studies reveal the following:

ParameterResultReference Range
Hemoglobin8.2 g/dL12.0-15.5 g/dL
Platelet count28,000/mm³150,000-400,000/mm³
Leukocyte count18,000/mm³4,500-11,000/mm³
Prothrombin time (PT)18 seconds11-15 seconds
Activated partial thromboplastin time (aPTT)45 seconds25-40 seconds
Fibrinogen95 mg/dL200-400 mg/dL

A peripheral blood smear demonstrates numerous mononuclear cells with intensely granulated cytoplasm and prominent needle-like cytoplasmic inclusions.

Which of the following is the most appropriate initial step in the management of this patient's condition?

  1. Administer all-trans retinoic acidAnswer
  2. B
    Perform a bone marrow aspiration and biopsy
  3. C
    Initiate induction chemotherapy with cytarabine and daunorubicin
  4. D
    Obtain an urgent computed tomography scan of the head
  5. E
    Administer intravenous tranexamic acid

Answer

Administer all-trans retinoic acid
The patient's presentation of bleeding, DIC (low fibrinogen, elevated PT/aPTT, thrombocytopenia), and a peripheral smear showing promyelocytes with Auer rods is pathognomonic for Acute Promyelocytic Leukemia (APL). The molecular driver of APL is the t(15;17) translocation, creating the PML-RARA fusion protein that halts myeloid differentiation. The primary cause of early mortality in APL is severe hemorrhage secondary to DIC, which is triggered by tissue factor released from the neoplastic promyelocytes. The most critical initial management step is the immediate administration of all-trans retinoic acid (ATRA). ATRA binds the mutated receptor, overriding the differentiation block and allowing the cells to mature, which rapidly halts the release of procoagulants and stabilizes the coagulopathy.

Step-by-Step Solution

1
Interpret the clinical and laboratory presentation.
The patient has pancytopenia with a consumptive coagulopathy characterized by prolonged PT/aPTT, thrombocytopenia, and hypofibrinogenemia, indicative of disseminated intravascular coagulation (DIC).
Recognizing DIC is crucial for identifying the immediate life-threatening risk of catastrophic hemorrhage.
2
Correlate the hematologic derangements with the peripheral smear findings.
The presence of heavily granulated mononuclear cells containing needle-like inclusions (Auer rods) in the setting of severe DIC is highly specific for Acute Promyelocytic Leukemia (APL).
APL promyelocytes contain primary granules loaded with tissue factor and annexin II, which trigger the coagulation cascade and cause DIC.
3
Determine the most appropriate immediate medical intervention.
All-trans retinoic acid (ATRA) must be administered immediately upon suspicion of APL, even before genetic confirmation of the t(15;17) translocation.
ATRA overcomes the retinoic acid receptor alpha (RARA) mutation, inducing the malignant promyelocytes to differentiate into mature neutrophils. This stops the release of procoagulant factors and resolves the life-threatening DIC.

Key Concept

Immediate administration of all-trans retinoic acid (ATRA) is the critical first step in suspected Acute Promyelocytic Leukemia (APL) to resolve life-threatening disseminated intravascular coagulation (DIC).
Rate this question

Topics

Neoplastic Processes

More questions from this topic